Canberra Times letters: Drug safer long-term choice

Updated April 24 2018 - 10:54pm, first published January 11 2017 - 8:56pm

Jennifer Heywood (Letters, January 6) wrote that safety must come first when considering whether to subsidise Kalydeco for children under six years old. I am a cystic fibrosis sufferer. Her objections are misguided.

Subscribe now for unlimited access.

$0/

(min cost $0)

or signup to continue reading

See subscription options

Get the latest Canberra news in your inbox

Sign up for our newsletter to stay up to date.

We care about the protection of your data. Read our Privacy Policy.